Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical and neurofunctional response to fluoxetine in childhood autism
2008-003712-36Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluoxetine in Autism Spectrum Disorder (ASD) and Psychopathology, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: ADI-R communication sub-score at week 20, ADI-R stereotyped behavior sub-score at week 20 and 1 more. Started Jun 2008; status: active.
02
Drugs
fluoxetine
03
Conditions
Autism Spectrum Disorder (ASD)Psychopathology
Beyond the preview
Go deeper on 2008-003712-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003712-36.